Report | November 2017
PAYING FOR VALUE
The growing cost and volatility of drug plans, driven by the growth in specialty and high-spend drugs, are threatening the sustainability of benefits plans. Employers, generally not satisfied with current drug management solutions, are looking for a more holistic, evidence-based approach to pharmacy benefits management. This new reality is challenging players across the private payer value chain to rethink their positioning and offering.
Perspective | August 2017
How resilient is your Wealth Management Business Model?
The wealth management industry is confronted with strong disruptive market forces that are challenging the current business model. business fundamentals which have driven the success of WM in the past decade are showing signs of weakness ...
Perspective | June 2017
The Future of Digital Wealth Advisors
Digital Advice is no longer just a Fintech-driven phenomenon. Digital advice in Canada is entering a third wave of innovation, led by incumbents.
Report | October 2016
Specialty Pharma Driving The Emergence Of “Access Hubs” For Private Payers
The rising cost of drugs, fuelled by the growing specialty drugs segment, is challenging the sustainability of private drug plans and forcing employers...
Report | October 2016
Rethinking the way drugs are paid: The opportunity for pharma
Today we pay for drugs, not health outcomes. Given the high cost of specialty medicines, the rapid growth of this segment is challenging the sustainability
Report | April 2016
Canada’s group benefits industry: Disruptions and strategies for the future
Canada’s group benefits industry has been remarkably resilient over the years. However, senior leaders in the industry are well aware of a number of ‘fault lines’
Case Study | February 2016
Transformation engineering improves operations performance
Developing an Operations Transformation Plan to enable a major Canadian Pension Fund to keep up with asset growth
Case Study | January 2015
Transformation during rapid industry change
Developing the strategy and business transformation plan to better align with patients and payers for a major pharmaceutical company